Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma

scientific article published on 05 April 2019

Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1634/THEONCOLOGIST.2018-0789
P932PMC publication ID6853117
P698PubMed publication ID30952822

P2093author name stringLei Zhang
Xinhua Wang
Ling Li
Hui Yu
Xin Li
Guannan Wang
Zhiyuan Zhou
Yu Chang
Mingzhi Zhang
Xiaoyan Feng
Wencai Li
Jingjing Wu
Xudong Zhang
Xiaolong Wu
Zhaoming Li
Zhenchang Sun
P2860cites workInnate and adaptive immune cells in the tumor microenvironmentQ27008342
Stromal gene signatures in large-B-cell lymphomasQ28302107
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.Q30966717
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsQ33613591
Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studiesQ33762117
Tumor-associated macrophages and survival in classic Hodgkin's lymphomaQ33962334
Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort studyQ34281919
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's DiseaseQ34480381
Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelQ35128731
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesQ35847903
Platelets at the interface of thrombosis, inflammation, and cancer.Q35904932
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtypeQ37026039
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myelomaQ37745835
Tumor-associated macrophages: from mechanisms to therapyQ38230880
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).Q38384261
The Complex Role of Neutrophils in Tumor Angiogenesis and MetastasisQ38721230
Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysisQ38897604
Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemiaQ44010380
Outcome with the hyper-CVAD regimens in lymphoblastic lymphomaQ44922356
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.Q45287423
How I treat T-cell acute lymphoblastic leukemia in adults.Q48188129
Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngersQ48515641
The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified.Q49085795
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.Q50016986
Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).Q52914722
Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.Q53643995
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyQ56966062
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisQ59276609
Treatment of lymphoblastic lymphoma in adultsQ69644909
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportQ73337895
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for BlQ73959236
Lymphoblastic lymphomaQ87876098
The pro-inflammatory role of platelets in cancerQ88188494
P433issue11
P304page(s)e1123-e1131
P577publication date2019-04-05
P1433published inOncologistQ2122327
P1476titleComplete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma
P478volume24